|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-7-6
|
|
pubmed:abstractText |
ACCOMPLISH is a "new-generation" hypertension trial assessing single-tablet combination therapy for initial treatment of high-risk hypertension. At baseline, 97% of subjects were treated with anti-hypertensive medication at entry, but only 37% of participants had blood pressure (BP) control (<140/90 mmHg). Single-tablet combination therapy may improve control rates.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0803-7051
|
|
pubmed:author |
pubmed-author:ACCOMPLISH Investigators,
pubmed-author:BakrisGeorge LGL,
pubmed-author:CushmanWilliamW,
pubmed-author:DahlöfBjörnB,
pubmed-author:GupteJitendraJ,
pubmed-author:HesterAllenA,
pubmed-author:JamersonKennethK,
pubmed-author:KjeldsenSverre ESE,
pubmed-author:LefkowitzMartinM,
pubmed-author:PapademetriouVasiliosV,
pubmed-author:PittBertramB,
pubmed-author:ShiVictorV,
pubmed-author:VelazquezEricE,
pubmed-author:WeberMichaelM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
80-6
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Exceptional early blood pressure control rates: the ACCOMPLISH trial.
|
|
pubmed:affiliation |
University of Michigan Health System, Division of Cardiovascular Medicine, Ann Arbor, Michigan 48106-0739, USA. jamerson@umich.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
